Table 6: Multivariate analysis for OS, DFS, and relapse.
OS | Univariate analysis, P | Multivariate analysis | |
---|---|---|---|
95% CI | P | ||
Age | 0.03 | ||
Cytogenetic at diagnosis | 0.001 | ||
Relapse aGvHD (no vs. grades 1-2 vs. grades 3-4) |
0.06 0.0001 |
1.2-16.8 |
0.001 |
aGvHD (grades 1-2 vs. 3-4) | 0.0001 | ||
cGvHD (no vs. limited vs. extensive) | 0.04 | ||
cGvHD (limited vs. extensive) | 0.06 | 0.9-228.9 | 0.01 |
Chimerism at 1 year after alloSCT | 0.05 | 0-3.5 | 0.007 |
DFS | |||
Cytogenetic at diagnosis Relapse rate Chimerism at 1 year after alloSCT Chimerism at the end of observation |
0.002 0.001 0.04 0.006 |
0.1-285529 |
0.001 |
Relapse rate | |||
Cytogenetic at diagnosis | 0.001 | 0.004-5.4 | 0.001 |
Platelets engraftment | 0.03 | ||
aGvHD (no vs. grades 1-2 vs. grades 3-4) | 0.005 | ||
aGvHD (grades 1-2 vs. 3-4) | 0.01 | ||
Chimerism at 1 year after alloSCT Chimerism at the end of observation |
0.01 0.04 |
OS: Overall Survival; DFS: Disease-Free Survival; aGvHD: Acute Graft Versus Host Disease; cGvHD: Chronic GvHD. P < 0.05 was considered significant.